ProfileGDS4718 / 1570156_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 44% 50% 31% 40% 36% 49% 50% 49% 48% 35% 43% 43% 48% 52% 49% 45% 41% 53% 44% 46% 47% 38% 32% 39% 42% 53% 39% 50% 45% 49% 53% 48% 46% 45% 50% 50% 49% 44% 43% 33% 40% 51% 42% 48% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1964844
GSM549102patient 115, normal, homogenized [OPG study]5.5204450
GSM549104patient 119, normal, homogenized [OPG study]4.5658731
GSM549108patient 138, normal, homogenized [OPG study]5.0691340
GSM549119patient 077, normal, homogenized [OPG study]4.7958436
GSM549133patient 032, cancer, homogenized [OPG study]5.3975149
GSM549139patient 042, cancer, homogenized [OPG study]5.4848850
GSM549099patient 107, normal, homogenized [OPG study]5.4459949
GSM549109patient 139, normal, homogenized [OPG study]5.4214648
GSM549110patient 046, normal, homogenized [OPG study]4.7732735
GSM549114patient 063, normal, homogenized [OPG study]5.0981443
GSM549122patient 082, normal, homogenized [OPG study]5.164643
GSM549134patient 033, cancer, homogenized [OPG study]5.3820548
GSM549136patient 036, cancer, homogenized [OPG study]5.5582852
GSM549140patient 044, cancer, homogenized [OPG study]5.4194949
GSM549111patient 047, normal, homogenized [OPG study]5.2072445
GSM549113patient 057, normal, homogenized [OPG study]4.9801441
GSM549132patient 031, cancer, homogenized [OPG study]5.70253
GSM549137patient 038, cancer, homogenized [OPG study]5.1794144
GSM549142patient 047, cancer, homogenized [OPG study]5.4427246
GSM549100patient 110, normal, homogenized [OPG study]5.3797947
GSM549107patient 135, normal, homogenized [OPG study]4.860838
GSM549115patient 068, normal, homogenized [OPG study]4.555632
GSM549116patient 072, normal, homogenized [OPG study]4.9108539
GSM549120patient 078, normal, homogenized [OPG study]5.1098342
GSM549131patient 030, cancer, homogenized [OPG study]5.6422753
GSM549118patient 074, normal, homogenized [OPG study]4.9617939
GSM549129patient 027, cancer, homogenized [OPG study]5.5083950
GSM549123patient 088, normal, homogenized [OPG study]5.1984645
GSM549124patient 006, cancer, homogenized [OPG study]5.4668249
GSM549126patient 015, cancer, homogenized [OPG study]5.6668853
GSM549128patient 025, cancer, homogenized [OPG study]5.4014448
GSM549103patient 117, normal, homogenized [OPG study]5.333846
GSM549117patient 073, normal, homogenized [OPG study]5.2018545
GSM549138patient 041, cancer, homogenized [OPG study]5.4922950
GSM549141patient 045, cancer, homogenized [OPG study]5.4982950
GSM549130patient 028, cancer, homogenized [OPG study]5.4731849
GSM549101patient 111, normal, homogenized [OPG study]5.2373944
GSM549105patient 128, normal, homogenized [OPG study]5.1746143
GSM549106patient 134, normal, homogenized [OPG study]4.607433
GSM549112patient 048, normal, homogenized [OPG study]5.0024640
GSM549125patient 011, cancer, homogenized [OPG study]5.583551
GSM549127patient 024, cancer, homogenized [OPG study]5.0716542
GSM549135patient 035, cancer, homogenized [OPG study]5.3825148